Welcome to our dedicated page for Ingersoll Rand SEC filings (Ticker: IR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ingersoll Rand Inc. filings document financial results, material events, governance actions and shareholder voting matters for a NYSE-listed industrial operating company. Form 8-K reports furnish quarterly and annual operating results, liquidity information, non-GAAP reconciliations and Regulation FD disclosures tied to company announcements.
Proxy materials cover annual meeting procedures, director elections, board committee structure, executive and director compensation, stockholder voting mechanics and governance practices. Additional 8-K filings record board size changes, independent director appointments, committee assignments and related capital-structure or governance disclosures.
Ingersoll Rand Inc. director Michelle Swanenburg reported the vesting and settlement of 130 restricted stock units on August 6, 2026. These RSUs were originally granted on August 6, 2025 and converted into 130 shares of common stock, increasing her direct holdings to 2,006 shares. The company indicated these transactions were not made under a Rule 10b5-1 trading plan.
FMR LLC and Abigail P. Johnson report their beneficial ownership of common stock of Ingersoll Rand Inc. in an amended Schedule 13G filing. FMR LLC reports beneficial ownership of 13,226,980.89 shares of common stock, representing 3.4% of the class. FMR LLC has sole voting power over 12,548,876.10 shares and sole dispositive power over 13,226,980.89 shares.
Abigail P. Johnson is reported with sole dispositive power over 13,226,980.89 shares but no sole or shared voting power. The filing states that one or more other persons may have rights to receive dividends or proceeds from these shares, but no such person holds more than five percent of the outstanding common stock.
Ingersoll Rand Inc. director Satpathy Aurobind purchased 11,538 shares of common stock on August 3, 2026. The shares were bought in open market transactions at a weighted average price of $86.678 per share, with individual trade prices ranging from $86.649 to $86.70, and Aurobind now holds 11,538 shares directly.
Ingersoll Rand Inc. reported Q2 2026 revenue of $2,048.8 million, up from $1,887.9 million a year earlier. Operating income rose to $380.3 million from $76.4 million, as the prior-year quarter included $265.8 million of goodwill and other intangible impairments and a $120.9 million loss on equity method investments. Net income attributable to Ingersoll Rand was $256.8 million versus a loss of $115.3 million, with diluted EPS of $0.66 versus $(0.29).
For the first six months of 2026, revenue was $3,896.0 million compared with $3,604.7 million, and net income attributable to Ingersoll Rand increased to $448.9 million from $71.2 million, or diluted EPS of $1.15 versus $0.18. Operating cash flow was $495.6 million, while capital expenditures were $63.3 million and net cash paid for acquisitions totaled $162.0 million. The company repurchased $338.8 million of treasury stock and paid $15.7 million in dividends.
At June 30, 2026, cash and cash equivalents were $1,173.5 million, total assets were $18,194.1 million, total debt (including current maturities) was $4,768.5 million, and total stockholders’ equity was $10,243.0 million. A $2,600.0 million senior unsecured revolving credit facility and a $2,600.0 million commercial paper program were both undrawn. Q2 2026 revenue included $1,622.1 million from Industrial Technologies and Services and $426.7 million from Precision and Science Technologies, with recent acquisitions such as Scinomix and Fox contributing to growth.
Ingersoll Rand Inc. reported second quarter 2026 revenue of $2,048.8 million, up from $1,887.9 million a year earlier. Net income attributable to Ingersoll Rand Inc. was $256.8 million, or $0.66 per diluted share, compared with a loss of $115.3 million, or $(0.29) per share, in the prior-year quarter. Adjusted net income attributable to Ingersoll Rand Inc. was $338.1 million and adjusted diluted EPS was $0.86, up from $323.7 million and $0.80. Adjusted EBITDA was $519.9 million versus $509.4 million, with a 25.4% margin.
The Industrial Technologies and Services segment generated $1,622.1 million of revenue and segment adjusted EBITDA of $434.5 million with a 26.8% margin, while Precision and Science Technologies delivered $426.7 million of revenue and $134.5 million of segment adjusted EBITDA, a 31.5% margin. Quarterly operating cash flow was $295.9 million and free cash flow was $268.9 million. As of June 30, 2026, liquidity totaled $3.8 billion, including $1.2 billion of cash and $2.6 billion of undrawn credit capacity, and net debt to adjusted EBITDA leverage was 1.7x.
The company deployed $110 million to acquisitions in the quarter, returned approximately $248 million to shareholders through $240 million of share repurchases and $8 million of dividends, and received a Moody’s credit rating upgrade to Baa1 in June 2026. It signed an agreement to acquire Fai Filtri s., expected to close in the fourth quarter of 2026, and expects to close the acquisition of a U.S.-based blower manufacturer on July 31, 2026. Updated full-year 2026 guidance calls for revenue growth of 4.5% to 6.5% versus 2025, adjusted EBITDA of $2,130 million to $2,190 million, adjusted EPS of $3.45 to $3.57, and free cash flow to adjusted net income conversion of about 95%.
Ingersoll Rand Inc. held its 2026 annual meeting of stockholders on June 11, 2026, where all management proposals were approved. Stockholders elected the full slate of directors for terms ending at the 2027 annual meeting. Quorum was strong, with 372,965,993 shares present, representing approximately 95.3% of the 391,332,297 common shares entitled to vote as of April 16, 2026. Stockholders ratified Deloitte & Touche LLP as independent auditor for fiscal 2026, approved on an advisory basis the executive compensation program, and approved the new Ingersoll Rand Inc. 2026 Omnibus Incentive Plan, which had been previously adopted by the board subject to stockholder approval.
Ingersoll-Rand Inc: T. Rowe Price Associates, Inc. reports beneficial ownership of 20,340,362 shares of Common Stock, representing 5.2% of the class as of 03/31/2026. The filing lists sole voting power for 19,904,108 shares and sole dispositive power for 20,340,362 shares.
The disclosure is presented on a Schedule 13G and is signed by Ellen York, Vice President, on 05/15/2026. The filer includes an explicit statement denying beneficial ownership in the text.
T. Rowe Price Investment Management, Inc. filed an amendment to a Schedule 13G reporting ownership of 17,786,425 shares of Ingersoll‑Rand Inc. common stock, representing 4.5% of the class as of 03/31/2026. The filing shows sole voting power of 17,119,009 shares and sole dispositive power of 17,786,425 shares. The amendment is signed on 05/15/2026.
Ingersoll-Rand, Inc. shows a 7.5% stake held by Capital Research Global Investors. Capital Research Global Investors reports beneficial ownership of 29,501,100 shares of Common Stock with 29,445,444 shares subject to sole voting power as of 03/31/2026.
The filing identifies the filing entity and related investment management affiliates and cites 391,617,994 shares believed to be outstanding, producing the disclosed 7.5% ownership figure. The form is a Schedule 13G beneficial-ownership disclosure signed on 05/11/2026.
Ingersoll Rand Inc. director Michelle Swanenburg exercised restricted stock units that vested and converted them into common shares. On May 5, 2026, 1,876 restricted stock units vested and were settled into 1,876 shares of common stock at a stated price of $0.00 per share. Following this routine equity award vesting, she directly holds 1,876 common shares, with the related restricted stock unit balance reduced to zero.